José Jesús Guzmán-Mendoza

Dr. José Jesús Guzmán-Mendoza

Universidad Autónoma de Chihuahua, Facultad de Medicina y Ciencias Biomédicas
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
JGJosé Jesús Guzmán-Mendoza
José Jesús Guzmán-Mendoza
Silvia Lorena Montes-FonsecaSilvia Lorena Montes-Fonseca
Silvia Lorena Montes-Fonseca
ERErnesto Ramos-Martínez
Ernesto Ramos-Martínez
CGCarmen González-Horta
Carmen González-Horta
PHPilar del Carmen Hernández-Rodríguez
Pilar del Carmen Hernández-Rodríguez
Blanca Sánchez-RamírezBlanca Sánchez-Ramírez
Blanca Sánchez-Ramírez
Carbon nanotubes (CNTs) are nanomaterials with multiple possible uses as drug carriers or in nanovaccine development. However, the toxicity of CNTs administered intravenously in in vivo models has not been fully described to date. This work aimed to evaluate the toxic effect of pristine multi-walled CNTs (UP-CNTs), purified (P-CNTs), or CNTs functionalized with fluorescein isothiocyanate (FITC-CNTs) administered by intravenous injection in BALB/c mice. Biochemical and histopathological parameters were analyzed at 1, 14, 29, and 60 days post-exposure. Pristine CNTs were the most toxic nanoparticles in comparison with P-CNTs or FITC-CNTs, increasing serum AST (≈ 180%), ALT (≈ 300%), and LDH (≈ 200%) levels at one day post-exposure. The urea/creatinine ratio suggested pre-renal injury at the 14th day accompanied of extensive lesions in kidneys, lungs, and liver. Biochemical and histological findings in mice exposed to P-CNTs had not significant differences compared to the controls. A lower toxic effect was detected in animals exposed to FITC-CNTs which was attributable to FITC toxicity. These results demonstrate that the purification process of CNTs reduces in vivo toxicity, and that toxicity in functionalized CNTs is dependent on the functionalized compound. Therefore, P-CNTs are postulated as potential candidates for safe biomedical applications using an intravenous pathway.

26 April 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
JGJosé Jesús Guzmán-Mendoza
José Jesús Guzmán-Mendoza
DCDavid Chavez-Flores
David Chavez-Flores
Silvia Lorena Montes-FonsecaSilvia Lorena Montes-Fonseca
Silvia Lorena Montes-Fonseca
CGCarmen González-Horta
Carmen González-Horta
EBErasmo Orrantia Borunda
Erasmo Orrantia Borunda
Blanca Sánchez-RamírezBlanca Sánchez-Ramírez
Blanca Sánchez-Ramírez
Carbon nanotubes (CNTs) have been proposed as nanovehicles for drug or antigen delivery since they can be functionalized with different biomolecules. For this purpose, different types of molecules have been chemically bonded to CNTs; however, this method has low efficiency and generates solvent waste. Candida antarctica lipase is an enzyme that, in an organic solvent, can bind a carboxylic to a hydroxyl group by esterase activity. The objective of this work was to functionalize purified CNTs with insulin as a protein model using an immobilized lipase of Candida antarctica to develop a sustainable functionalization method with high protein attachment. The functionalized CNTs were characterized by scanning electron microscope (SEM), Raman spectroscopy, Fourier-transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS–PAGE). The enzymatic functionalization of insulin on the surface of the CNTs was found to have an efficiency of 21%, which is higher in conversion and greener than previously reported by the diimide-activated amidation method. These results suggest that enzymatic esterification is a convenient and efficient method for CNT functionalization with proteins. Moreover, this functionalization method can be used to enhance the cellular-specific release of proteins by lysosomal esterases.

14 December 2023 in BioNanoScience
Verified
Journal Article
Open access
PDF file
JGJosé Jesús Guzmán-Mendoza
José Jesús Guzmán-Mendoza
Blanca Sánchez-RamírezBlanca Sánchez-Ramírez
Blanca Sánchez-Ramírez
OCOscar E. Cigarroa-Mayorga
Oscar E. Cigarroa-Mayorga
EBErasmo Orrantia Borunda
Erasmo Orrantia Borunda
Patricia Talamás-RohanaPatricia Talamás-Rohana
Patricia Talamás-Rohana
Important developments in nanoparticle-based therapies have occurred in recent years. Carbon nanotubes (CNTs) are among the most valuable nanoparticles because of their physicochemical properties and functionalization possibilities; therefore, they are proposed as peptide carriers for immunotherapy. Immunotherapy has been explored as a promising treatment for ovarian cancer (OvCa), and it has been reported that macrophage polarization to M1 and M2 phenotypes plays a pivotal role in OvCa initiation, progression, and metastasis, providing therapeutic targets for macrophage-targeted treatment. In this work, we explored the initial stages of designing CNT-based immunotherapy for OvCa using fucosyltransferase-4-derived T-cell epitopes conjugated with CNTs (f-CNTs). Their cytotoxicity and biological interactions were analyzed in macrophages (J774A.1) and human ovarian cancer cells (SKOV-3). Here,f-CNTs did not show cytotoxicity at concentrations < 6 μg/mL; additionally, they induced morphological changes and activation in macrophages; time-dependent uptake in lysosomes; production of M1-like cytokines; upregulation of CD80, CD86, and major histocompatibility complex II (MHC II); and downregulation of arginase-1 (ARG-1). In conclusion,f-CNTs exhibited biocompatibility in both cell lines and displayed M1-like polarization in macrophages, and we propose their exploration as a peptide carrier system for macrophage activation and polarization in ovarian cancer immunotherapy.

23 January 2024 in Cell Biology International
Verified
Journal Article
Closed access
NANayely Paulina Alvear‐Hernandez
Nayely Paulina Alvear‐Hernandez
VHVerónica Ivonne HernándezRamírez
Verónica Ivonne HernándezRamírez
JVJulio César Villegas-Pineda
Julio César Villegas-Pineda
JOJuan Carlos Osorio-Trujillo
Juan Carlos Osorio-Trujillo
JGJosé Jesús Guzmán-Mendoza
José Jesús Guzmán-Mendoza
Patricia Talamás-RohanaPatricia Talamás-Rohana
Patricia Talamás-Rohana

18 June 2026 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Open access
AVAlejandro Velarde-Calderón
Alejandro Velarde-Calderón
JGJosé Jesús Guzmán-Mendoza
José Jesús Guzmán-Mendoza
EBErasmo Orrantia Borunda
Erasmo Orrantia Borunda
DCDavid Chavez-Flores
David Chavez-Flores
MGMaría del Carmen González-Horta
María del Carmen González-Horta
Blanca Sánchez-RamírezBlanca Sánchez-Ramírez
Blanca Sánchez-Ramírez
The development of effective vaccines against Entamoeba histolytica remains a major challenge, particularly for preventing amoebic liver abscess (ALA). In this study, carbon nanotubes (CNTs) were evaluated as nanocarriers through bioconjugation with L220-derived peptides (PL220-CNTs). CNTs were synthesized, purified, and characterized, confirming successful bioconjugation (42%). In vitro, PL220-CNTs exhibited negligible cytotoxicity in J774 macrophages and induced morphological changes characterized by cytoplasmic prolongations and phagosome-like structures. In vivo, subcutaneous immunization of hamsters induced antigen-specific responses, including splenocyte proliferation and increased IL-17A production, suggesting the participation of an IL-17A-associated immune response. Notably, animals immunized with PL220-CNTs exhibited limited antibody production against L220-derived peptides, suggesting a predominantly cellular immune response. PL220-CNT immunization conferred complete protection against ALA following intrahepatic challenge, whereas L220 alone provided partial protection. Histological analyses revealed preservation of hepatic architecture and reduced inflammatory damage in PL220-CNT-immunized animals. Overall, these findings support the potential of bioconjugated CNTs as immunomodulatory nanoplatforms for vaccine development against amoebiasis and other infectious diseases.

8 November 2026 in Cancer Biology & Therapy
Verified
Journal Article
Open access
ACAlejandro Velarde Calderón
Alejandro Velarde Calderón
JGJosé Jesús Guzmán-Mendoza
José Jesús Guzmán-Mendoza
Blanca Sánchez-RamírezBlanca Sánchez-Ramírez
Blanca Sánchez-Ramírez
Giuseppina  De SimoneGiuseppina De Simone
Giuseppina De Simone
Patricia Talamás-RohanaPatricia Talamás-Rohana
Patricia Talamás-Rohana
1. Ovarian cancer (OC) is the gynecological cancer with the highest mortality rate worldwide. 1 Despite advances in its clinical management, the overall survival of most patients rarely exceeds fiv...